181 related articles for article (PubMed ID: 36430670)
1. Comparison of the Anticancer Effects of Arvanil and Olvanil When Combined with Cisplatin and Mitoxantrone in Various Melanoma Cell Lines-An Isobolographic Analysis.
Marzęda P; Wróblewska-Łuczka P; Florek-Łuszczki M; Drozd M; Góralczyk A; Łuszczki JJ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430670
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines-An Isobolographic Analysis.
Marzęda P; Wróblewska-Łuczka P; Drozd M; Florek-Łuszczki M; Załuska-Ogryzek K; Łuszczki JJ
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743195
[TBL] [Abstract][Full Text] [Related]
3. AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.
Marzęda P; Wróblewska-Łuczka P; Florek-Łuszczki M; Góralczyk A; Łuszczki JJ
Pharmacol Rep; 2024 Feb; 76(1):154-170. PubMed ID: 38019413
[TBL] [Abstract][Full Text] [Related]
4. Fraxetin Interacts Additively with Cisplatin and Mitoxantrone, Antagonistically with Docetaxel in Various Human Melanoma Cell Lines-An Isobolographic Analysis.
Wróblewska-Łuczka P; Grabarska A; Góralczyk A; Marzęda P; Łuszczki JJ
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613654
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Activity of Amantadine and Evaluation of Its Interactions with Selected Cytostatics in Relation to Human Melanoma Cells.
Krasowska D; Gerkowicz A; Wróblewska-Łuczka P; Grabarska A; Załuska-Ogryzek K; Krasowska D; Łuszczki JJ
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886997
[TBL] [Abstract][Full Text] [Related]
6. Synergy, Additivity and Antagonism between Esculetin and Six Commonly Used Chemotherapeutics in Various Malignant Melanoma Cell Lines-An Isobolographic Analysis.
Wróblewska-Łuczka P; Góralczyk A; Łuszczki JJ
Molecules; 2023 May; 28(9):. PubMed ID: 37175299
[TBL] [Abstract][Full Text] [Related]
7. Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells.
Wróblewska-Łuczka P; Grabarska A; Florek-Łuszczki M; Plewa Z; Łuszczki JJ
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430369
[TBL] [Abstract][Full Text] [Related]
8. Non-pungent long chain capsaicin-analogs arvanil and olvanil display better anti-invasive activity than capsaicin in human small cell lung cancers.
Hurley JD; Akers AT; Friedman JR; Nolan NA; Brown KC; Dasgupta P
Cell Adh Migr; 2017 Jan; 11(1):80-97. PubMed ID: 27196129
[TBL] [Abstract][Full Text] [Related]
9. Arvanil, olvanil, AM 1172 and LY 2183240 (various cannabinoid CB1 receptor agonists) increase the threshold for maximal electroshock-induced seizures in mice.
Tutka P; Wlaź A; Florek-Łuszczki M; Kołodziejczyk P; Bartusik-Aebisher D; Łuszczki JJ
Pharmacol Rep; 2018 Feb; 70(1):106-109. PubMed ID: 29335158
[TBL] [Abstract][Full Text] [Related]
10. Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs.
Wróblewska-Łuczka P; Góralczyk A; Łuszczki JJ
Cells; 2023 Jun; 12(12):. PubMed ID: 37371063
[TBL] [Abstract][Full Text] [Related]
11. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells.
Jendželovská Z; Jendželovský R; Hiľovská L; Kovaľ J; Mikeš J; Fedoročko P
Toxicol In Vitro; 2014 Oct; 28(7):1259-73. PubMed ID: 24994473
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
[TBL] [Abstract][Full Text] [Related]
13. Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.
Ayash L; Korbut T; Herman TS; Teicher BA
Cancer Lett; 1991 Dec; 61(1):7-14. PubMed ID: 1764699
[TBL] [Abstract][Full Text] [Related]
14. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro.
Fiorentzis M; Kalirai H; Katopodis P; Seitz B; Viestenz A; Coupland SE
Neoplasma; 2018; 65(2):210-215. PubMed ID: 29534581
[TBL] [Abstract][Full Text] [Related]
16. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid enhances cisplatin cytotoxicity in melanoma cells.
Chodurek E; Orchel A; Gruchlik A; Aleksander E; Gołabek K; Dzierzewicz Z
Acta Pol Pharm; 2012; 69(6):1298-302. PubMed ID: 23285693
[TBL] [Abstract][Full Text] [Related]
18. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
19. Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin.
Hammouda MB; Riahi-Chebbi I; Souid S; Othman H; Aloui Z; Srairi-Abid N; Karoui H; Gasmi A; Magnenat EM; Wells TNC; Clemetson KJ; Rodríguez-López JN; Essafi-Benkhadir K
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):600-614. PubMed ID: 29196192
[TBL] [Abstract][Full Text] [Related]
20. Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells - An Isobolographic Analysis.
Jarząb A; Łuszczki JJ; Guz M; Gumbarewicz E; Polberg K; Stepulak A
Anticancer Res; 2017 Mar; 37(3):1067-1074. PubMed ID: 28314266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
